Rapid reduction of glucocorticoid (GC) doses to 7.5 mg/day or less within 6 months may not worsen renal outcomes or increase relapse in patients with proliferative lupus nephritis (LN), recent study ...

Chronic kidney disease (CKD) and hypertension are common health problems among childhood cancer survivors with potentially life-threatening sequelae.

Only incidence and prevalence rates attributable to keratinocyte cancer, DALYs attributable to BCC would increase by 2050 ...

Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes.

Health care data breaches that compromised protected health information more than doubled from 2010 to 2024 in the US, data suggest.

Belimumab, a monoclonal antibody, added to standard therapy may treat a broader range of patients with lupus nephritis than previously appreciated.

Moderna had already started a Phase 1/2 trial of its bird flu (H5N1) vaccine and reported strong early results.

The prices charged at the US launch of targeted cancer therapies have increased well above the rate of inflation every year since 2012.

Disability prevalence 14.1 percent for current smokers, 6.8 percent for never smokers, and 12.6 percent for former smokers.

Adding zilebesiran to a thiazide diuretic or calcium channel blocker may lead to further blood pressure reduction in patients with uncontrolled hypertension. Zilebesiran added to hypertension ...

Cuts to Medicare reimbursement could prevent cancer patients from accessing care and force practices to downsize or close, radiation oncologists say.

A prospective study of sex hormone use in patients seeking transgender treatments suggests how these hormones may influence kidney health.